English
Home > Products > 138786-67-1

China 138786-67-1 Factory

Our goal is usually to consolidate and improve the high quality and service of existing solutions, meanwhile continuously create new items to meet unique customers' requires for 138786-67-1,CAS NO 138786-67-1,Pantoprazole API,Pantoprazole Sodium, If you're interested in any of our merchandise or wish to talk about a tailored buy, you should really feel totally free to get hold of us.
138786-67-1, Our company regards "reasonable prices, efficient production time and good after-sales service" as our tenet. We hope to cooperate with more customers for mutual development and benefits. We welcome potential buyers to contact us.

Related Products

Hot Products

  • Vilazodone Hydrochloride

    Vilazodone Hydrochloride

    Product Name:Vilazodone Hydrochloride
    Molecular Formula:C26H28ClN5O2
    Molecular Weight;477.98582
    CAS Registry Number;163521-08-2
  • Hexyl Chloroformate

    Hexyl Chloroformate

    Product Name:Hexyl Chloroformate
    Molecular Formula:C7H13ClO2
    Molecular Weight:164.63
    CAS Registry Number:6092-54-2
  • Ofloxacin hydrochloride

    Ofloxacin hydrochloride

    Product Name:Ofloxacin hydrochloride
    Molecular Formula:C18H20FN3O4.HCl
    Molecular Weight;397.83
    CAS Registry Number;118120-51-7
  • 4-tert-Butylbenzyl chloride

    4-tert-Butylbenzyl chloride

    Product Name:4-tert-Butylbenzyl chloride
    Molecular Formula:C11H15Cl
    Molecular Weight:182.69
    CAS Registry Number:19692-45-6
  • Crotamiton

    Crotamiton

    Product Name:Crotamiton
    Molecular Formula:C13H17NO
    Molecular Weight:203.28
    CAS Registry Number:483-63-6
  • HATU

    HATU

    Product Name:HATU
    Molecular Formula:C10H15F6N6OP
    Molecular Weight:380.24
    CAS Registry Number:148893-10-1
  • Related Blog
  • Reviews

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

Related Search

CAS NO 138786-67-1

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept